Financial results - ROST CLINICAL RESEARCH SRL

Financial Summary - Rost Clinical Research Srl
Unique identification code: 32429893
Registration number: J40/13614/2013
Nace: 7211
Sales - Ron
150.348
Net Profit - Ron
119.100
Employees
1
Open Account
Company Rost Clinical Research Srl with Fiscal Code 32429893 recorded a turnover of 2024 of 150.348, with a net profit of 119.100 and having an average number of employees of 1. The company operates in the field of Cercetare-dezvoltare in biotehnologie having the NACE code 7211.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Rost Clinical Research Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 64.382 142.375 47.448 62.904 11.562 0 74.243 82.942 80.662 150.348
Total Income - EUR 64.387 142.713 47.518 62.949 11.917 2.533 74.606 82.858 80.759 157.624
Total Expenses - EUR 42.326 67.409 38.837 12.639 8.301 2.073 15.093 22.598 25.144 34.876
Gross Profit/Loss - EUR 22.061 75.304 8.681 50.310 3.616 460 59.513 60.260 55.614 122.748
Net Profit/Loss - EUR 20.130 70.177 7.563 48.423 3.259 384 58.020 59.448 54.871 119.100
Employees 1 2 1 0 0 0 1 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 87.4%, from 80.662 euro in the year 2023, to 150.348 euro in 2024. The Net Profit increased by 64.535 euro, from 54.871 euro in 2023, to 119.100 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Rost Clinical Research Srl

Rating financiar

Financial Rating -
ROST CLINICAL RESEARCH SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Rost Clinical Research Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Rost Clinical Research Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Rost Clinical Research Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Rost Clinical Research Srl - CUI 32429893

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 24.353 24.489 23.066 26.072 24.104 23.352 20.329 19.489 18.383 17.345
Current Assets 18.547 55.951 9.996 23.492 3.123 3.299 41.374 46.930 50.197 106.664
Inventories 0 0 45 44 107 0 0 0 0 0
Receivables 6.271 10.838 7.695 23.486 3.024 2.679 40.090 46.472 50.230 87.585
Cash 12.276 45.113 2.256 -38 -8 619 1.284 458 -34 19.079
Shareholders Funds 39.005 70.230 31.855 48.535 25.566 25.465 58.710 59.497 55.121 119.148
Social Capital 45 45 44 43 42 41 40 41 40 40
Debts 4.128 10.449 1.252 1.085 1.672 1.195 2.993 6.941 13.463 4.861
Income in Advance 9 19 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "7211 - 7211"
CAEN Financial Year 7211
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 106.664 euro in 2024 which includes Inventories of 0 euro, Receivables of 87.585 euro and cash availability of 19.079 euro.
The company's Equity was valued at 119.148 euro, while total Liabilities amounted to 4.861 euro. Equity increased by 64.335 euro, from 55.121 euro in 2023, to 119.148 in 2024.

Risk Reports Prices

Reviews - Rost Clinical Research Srl

Comments - Rost Clinical Research Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.